You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Patent: 9,677,061


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,677,061
Title:Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
Abstract: Provided are soluble neutral active Hyaluronidase Glycoproteins (sHASEGP\'s), methods of manufacture, and their use to facilitate administration of other molecules or to alleviate glycosaminoglycan associated pathologies. Minimally active polypeptide domains of the soluble, neutral active sHASEGP domains are described that include asparagine-linked sugar moieties required for a functional neutral active hyaluronidase domain. Included are modified amino-terminal leader peptides that enhance secretion of sHASEGP. Sialated and pegylated forms of the sHASEGPs also are provided. Methods of treatment by administering sHASEGPs and modified forms thereof also are provided.
Inventor(s): Bookbinder; Louis H. (San Diego, CA), Kundu; Anirban (San Diego, CA), Frost; Gregory I. (Del Mar, CA)
Assignee: Halozyme, Inc. (San Diego, CA)
Application Number:12/928,890
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 9,677,061

Introduction

Understanding the intricacies of a patent, particularly its claims and the broader patent landscape, is crucial for inventors, legal professionals, and businesses. This article provides a comprehensive and critical analysis of the claims and the patent landscape surrounding United States Patent 9,677,061, focusing on key aspects such as claim construction, patent search tools, international patent considerations, and the impact of AI on patent applications.

Understanding Patent Claims

Patent claims are the legal boundaries that define the scope of protection afforded by a patent. They must be clear, concise, and distinguish the invention from prior art[2].

Claim Construction

The construction of claims is a critical step in patent litigation. For example, in the case of NSS v. Autodesk, the court's decision on claim indefiniteness was reversed due to an incorrect legal standard. The Federal Circuit emphasized that claims must point out what the invention is and define the scope of protection, distinguishing it from prior art[2].

The Patent 9,677,061: A Case Study

While the specific details of Patent 9,677,061 are not provided here, a general analysis can be applied based on common practices and legal precedents.

Claim Analysis

  • Clarity and Specificity: Claims must be clear and specific to avoid indefiniteness. Any ambiguity can lead to legal challenges, as seen in the NSS v. Autodesk case.
  • Scope of Protection: The claims should define the invention in a way that distinguishes it from prior art. This involves a detailed description in the specification and drawings[2].

Specification and Drawings

The specification and drawings are integral to understanding the claims. They provide the context and technical details necessary to interpret the claims accurately. For instance, in the NSS v. Autodesk case, the specification included detailed descriptions and flowcharts that helped clarify the claims[2].

Patent Search Tools and Resources

Conducting thorough patent searches is essential to ensure the novelty and non-obviousness of an invention.

USPTO Resources

  • Patent Public Search: This tool offers enhanced access to prior art through modern interfaces, replacing legacy tools like PubEast and PubWest[1].
  • Global Dossier: This service provides access to file histories of related applications from participating IP Offices, helping users identify office actions and related applications[1].
  • Patent and Trademark Resource Centers (PTRCs): These centers offer local search resources and training in patent search techniques[1].

International Patent Searches

To ensure global novelty, it is crucial to search international patent databases:

  • European Patent Office (EPO): Provides access to European patent databases through esp@cenet[1].
  • Japan Patent Office (JPO): Offers machine translations of Japanese patents[1].
  • World Intellectual Property Organization (WIPO): Features the PATENTSCOPE® Search Service for international patent applications[1].

Impact of AI on Patent Applications

The increasing use of AI tools in patent drafting and searching introduces new challenges and considerations.

AI Contributions and Disclosure

If AI tools are used in drafting or editing patent applications, the contributions must be disclosed to the USPTO. This includes any material information that could affect patentability, such as evidence that an AI system made significant contributions to the invention[3].

Accuracy and Verification

Practitioners must review and verify the accuracy of documents prepared with AI tools to ensure they do not introduce inaccurate statements or omit material information[3].

Economic and Policy Implications

The value and impact of patents extend beyond legal boundaries, influencing economic growth and policy decisions.

Patent Values and Economic Growth

Research by the USPTO's Office of the Chief Economist (OCE) shows that patent characteristics and renewal outcomes can estimate the lifetime private values of patents. This research highlights the significance of patent timing and citation dynamics in relation to economic growth[4].

Patent Litigation Data

The USPTO provides comprehensive patent litigation data, which can be used to study patent litigation trends and their economic implications. This data includes information on litigating parties, court locations, and important dates in litigation history[4].

International Patent Landscape

The global patent landscape is complex and interconnected.

Global Dossier and Common Citation Document (CCD)

Tools like the Global Dossier and CCD facilitate the integration of the global patent system by providing access to related applications and citation data across participating IP Offices[1].

Machine Translations

Many international patent offices offer machine translations of patents, which can aid in searching and understanding foreign patents. For example, the EPO, JPO, and CNIPA provide such services[1].

Key Takeaways

  • Clear and Specific Claims: Ensure that patent claims are clear, concise, and distinguish the invention from prior art.
  • Thorough Patent Searches: Use comprehensive search tools and resources, including USPTO and international databases, to verify novelty and non-obviousness.
  • AI Tool Considerations: Disclose AI contributions and verify the accuracy of documents prepared with AI tools.
  • Economic and Policy Implications: Understand the economic value of patents and their impact on policy decisions.
  • Global Patent Integration: Utilize tools like the Global Dossier and CCD to navigate the international patent landscape.

FAQs

Q1: What is the importance of claim construction in patent litigation? Claim construction is crucial as it defines the scope of protection and distinguishes the invention from prior art. Incorrect claim construction can lead to legal challenges and invalidation of claims.

Q2: How can I conduct a thorough patent search? Use the USPTO's Patent Public Search tool, Global Dossier, and international patent databases such as those provided by the EPO, JPO, and WIPO.

Q3: What are the risks associated with using AI tools in patent applications? AI tools can introduce inaccuracies or omit material information. Practitioners must review and verify the accuracy of documents prepared with AI tools.

Q4: How does the USPTO provide economic research on patents? The USPTO's Office of the Chief Economist conducts research and publishes working papers on patent values, citation dynamics, and economic growth.

Q5: What resources are available for searching foreign patents? Resources include machine translations provided by the EPO, JPO, and CNIPA, as well as the PATENTSCOPE® Search Service by WIPO.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. UNITED STATES COURT OF APPEALS FOR THE FEDERAL CIRCUIT: https://cafc.uscourts.gov/opinions-orders/20-2257.OPINION.10-17-2022_2019495.pdf
  3. U.S. Patent Office Issues Additional Guidance on Use of AI Tools: https://www.bipc.com/united-states-patent-office-issues-guidance-on-use-of-ai-tools
  4. USPTO - Working papers and book chapters: https://www.uspto.gov/ip-policy/economic-research/publications/working-papers

More… ↓

⤷  Subscribe

Details for Patent 9,677,061

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Bausch & Lomb Incorporated VITRASE hyaluronidase Injection 021640 May 05, 2004 ⤷  Subscribe 2023-03-05
Bausch & Lomb Incorporated VITRASE hyaluronidase Injection 021640 December 02, 2004 ⤷  Subscribe 2023-03-05
Amphastar Pharmaceuticals, Inc. AMPHADASE hyaluronidase Injection 021665 October 26, 2004 ⤷  Subscribe 2023-03-05
Akorn, Inc. HYDASE hyaluronidase Injection 021716 October 25, 2005 ⤷  Subscribe 2023-03-05
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.